Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study
Clinical trial NCT05295394 · WITHDRAWN
Trial details
- NCT number
- NCT05295394
- Sponsor
- Pedro Cahn
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2022-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.